MacKay, I.F. et al. 2018. ADVERSE DRUG REACTIONS ASSOCIATED WITH THE USE OF RIBAVIRIN IN THE TREATMENT OF SEVERE ACUTE RESPIRATORY SYNDROME (SARS). Journal of Population Therapeutics and Clinical Pharmacology. 12, 1 (Dec. 2018).